United Biotech Private Limited
United Biotech Private Limited
Badarpur, New Delhi, Delhi
SEND SMS
SEND EMAIL

Anticancer Drugs

Manufacturer of high end anticancer drugs, offers you a complete range of oncology products for various types of cancers including lung cancer, breast cancer, cervical cancer, colorectal cancer, prostate cancer and leukemias.

Carboplatin Injection BP 150mg and 450mg

Carboplatin Injection BP 150mg and 450mg
  • Carboplatin Injection BP 150mg and 450mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageHospital, Clinical
Dose360mg
Product TypeFinished Product
BrandUnited Biotech
TypeInjection
Active saltCyclophosphamide

Indications :

  • Respiratory Tract infections
  • Skin & Soft Tissue Infections
  • Intra-abdominal infections
  • Septicemia
  • Pelvic Inflammatory Disease
  • Bone and joint infections

Dosages :
Single agent therapy : 360 mg/m2 I.V. on day 1 every 4 weeks
Combination therapy with cyclophosphamide : Carboplatin : 300 mg/m2 I.V. on day 1 every 4 weeks for six cycles.
Cyclophosphamide : 600 mg/m2 I.V. on day 1 every 4 weeks for six cycle.
Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment : Required.

Packing :
10 Single Dose Vials of 150 mg
1 Single Dose Vial of 450 mg

 

Request
Callback
Yes! I am Interested

Docetaxel Injection Concentrate 20mg, 80mg and 120mg

Docetaxel Injection Concentrate 20mg, 80mg and 120mg
  • Docetaxel Injection Concentrate 20mg, 80mg and 120mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose>35ml
ApplicationAnti Infective & Common Disease Medicines
Injectable FormSolution
Injection SiteIntramuscular
Packaging TypeGlass Bottle
Medicine TypeAllopathic
PortableYes
SterilizedYes

Indications :
  • Breast cancer
  • Prostate cancer 
  • Non-small cell lung cancer 
  • Gastric Adenocarcinoma
  • Head and Neck Cancer 

Dosage :
Breast Cancer :
60-100 mg/m2 administered intravenously over 1 hour every 3 weeks.
Non-Small Cell Lung Cancer :
75 mg/m2 administered intravenously over 1 hour every 3 weeks.
Prostate cancer : 75 mg/m2 every 3 weeks
Gastric Adenocarcinoma :
75 mg/m2 as a 1 hour intravenous infusion.
Head and Neck Cancer :
75 mg/m2 as a 1 hour intravenous infusion.
Dosage Adjustment :
Renal Impairment : Not Required.
Hepatic Impairment : Required.

Packing :
1 Vial of 20 mg
1 Vial of 80 mg
1 Vial of 120 mg
Request
Callback
Yes! I am Interested

Flutamide Tablets 250mg

Flutamide Tablets 250mg
  • Flutamide Tablets 250mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Type Of MedicinesAllopathic
ApplicationAnti Infective And Common Disease Medicines
Dose101mg-250mg
GenderUnisex
BrandUnited Biotech
Packaging TypeStrips

Indications :
  • Prostatic Carcinoma (Stage B2-C Prostatic Carcinoma and Stage D2 metastatic Carcinoma)

Dosage :
250 mg every 8 hours (Total daily dose 750 mg).
Dosage Adjustment :
Renal Impairment : Dosing adjustments for renal impairment are not indicated for flutamide.
Hepatic Impairment : Discontinue Flutamide if AST ≥ 2 x ULN or bilirubin is > ULN.

Packing :
1 Strip of 10 Tablets
Request
Callback
Yes! I am Interested

Epirubicin Hydrochloride For Injection 10mg And 50mg

Epirubicin Hydrochloride For Injection 10mg And 50mg
  • Epirubicin Hydrochloride For Injection 10mg And 50mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageHospital, Clinical
Packaging Size10,50 mg
Product TypeFinished Product
BrandUnited Biotech
Injectable FormLiquid

Indications :
  • Breast Cancer

Dosage :
Epirubicin is given in repeated 3 to 4 week cycles.
The total dose of Epirubicin may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. The recommended dosages of Epirubicin are as follows :
Starting Doses : The recommended starting dose of Epirubicin is 100 to 120 mg/m2. The following regimens were used in the trials supporting use of Epirubicin as a component of adjuvant therapy in patients with axillary-node positive breast cancer;
CEF-120 : Cyclophosphamide-75 mg/m2 PO Day 1-14 Epirubicin- 60 mg/m2 IV Day 1, 8 -500 mg/m2 IV Day 1, 8 Repeated every 28 days for 6 cycles
FEC-100 :- 500 mg/m2, Epirubicin- 100 mg/m2, Cyclophosphamide- 500 mg/m2
Dosage Adjustment :
Renal Impairment :Administer with caution.
Hepatic Impairment : Required.


Request
Callback
Yes! I am Interested

Etoposide Injection 100mg

Etoposide Injection 100mg
  • Etoposide Injection 100mg
Ask For Price
Product Price :Get Latest Price

Product Details:

BrandUnited Biotech
UsageClinical
Packaging Size1 Vial of 100 mg
Packaging TypeGlass Bottle
Form of MedicineInjection

Indications :
  • Small cell lung cancer
  • Refractory testicular tumors

Dosage :
ORAL : 2 times 35 mg/m2/ day for 4 days to 50 mg/m2/day for 5 days.
IV : 35 mg/m2/ day for 4 days to 50 mg/m2/day for 5 days
IV : 50 to 100 mg/m2/day on days 1 through 5 to 100 mg/m2/day on days 1, 3 and 5.


Request
Callback
Yes! I am Interested

Bicalutamide Tablets 50mg

Bicalutamide Tablets 50mg
  • Bicalutamide Tablets 50mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength50 mg
Packaging Size1 strip of 10 tablets
Gender Male
Dosage FormTablet
BrandUnited BIotech

Indications :
  • For the treatment of Stage D2 metastatic carcinoma of the prostate cancer in combination with a Luteinizing hormone - releasing hormone (LHRH) analog. 

Dosage :
The ideal dose for bicalutamide therapy with an LHRH analog is one 50 mg tablet once daily (morning or evening) without regard to meals.

Packing : 1 Strip of 10 Tabs.
Request
Callback
Yes! I am Interested

Erlotinib 100mg and 150mg

Erlotinib 100mg and 150mg
  • Erlotinib 100mg and 150mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageClinical, Hospital
Dose100mg and 150mg
Packaging Size1 Strip of 10 Tablet
Packaging TypeTablet

Indications :
  • Non-small cell lung cancer.
  • Pancreatic cancer.

Dosage :
Nonsmall cell lung cancer: 150mg once daily
Pancreatic cancer : 100mg once daily
Renal Impairment: Less than 9% of a single dose is excreted in the urine. No clinical studies have been conducted in patients with compromised renal function

Request
Callback
Yes! I am Interested

Bortezomib 2mg and 3.5mg

Bortezomib 2mg and 3.5mg
  • Bortezomib 2mg and 3.5mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size1 Vial of 2mg
Packaging TypeInjection
Dose/Strength (ex. 1 mg or 1 ml)3.5 mg
UsageClinical, Hospital

Indications :
  • Multiple myeloma
  • Mantle cell lymphoma

Dosage :
Dosage in Previously Untreated Multiple Myeloma.
Bortezomib is administered as a 3-5 second bolus IV injection in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles as shown in Table 1. In Cycles 1-4, Bortezomib is administered twice weekly (days 1, 4, 8, 11, 22, 25, 29 and 32). In Cycles 5-9, Bortezomib is administered once weekly (days 1, 8, 22 and 29). At least 72 hours should elapse between consecutive doses of Bortezomib.

Dosage in Relapsed Multiple Myeloma and Mantle Cell Lymphoma.
Bortezomib (1.3mg/m²/dose) is administered as a 3-5 second bolus IV injection twice weekly for 2 weeks (Days 1, 4, 8 & 11) followed by a 10-day rest period (Days 12-21). For extended therapy of more than 8 cycles, Bortezomib may be administered on the standard schedule or on a maintenance schedule of once weekly for 4 weeks (Days 1, 8, 15, & 22) followed by a 13-day rest period (Days 23 to 35). At least 72 hours should elapse between consecutive doses of Bortezomib.
Renal Impairment: Not Required.


Packing :
1 Vial of 2mg
1 Vial of 3.5mg
Request
Callback
Yes! I am Interested

Dacarbazine for Injection 100mg, 200mg and 500mg

Dacarbazine for Injection 100mg, 200mg and 500mg
  • Dacarbazine for Injection 100mg, 200mg and 500mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageHospital, Clinical
Dose500 mg
Packaging Size1 Vial of 100 mg
Packaging TypeInjection

Indications :
  • Metastatic Malignant Melanoma
  • Hodgkin's Disease

Dosage :
Doses from 2-4.5 mg/kg/day for 10 days up to 850 mg/m2 as a single dose may be given at intervals of 3-4 weeks.
The administration is by the intravenous route only.
Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment: Administer with caution.

Packing :
1 Vial of 100 mg
1 Vial of 200 mg
1 Vial of 500 mg
Request
Callback
Yes! I am Interested

Fluorouracil Injection 250mg And 500mg

Fluorouracil Injection 250mg And 500mg
  • Fluorouracil Injection 250mg And 500mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose 250mg and 500mg
UsageClinical, Hospital
Packaging Size1 Pack of 5 Ampoules
Packaging TypeInjection

Indications :
  • In combination for the palliative treatment of malignant tumors, particularly of the breast, colon, and rectum.
  • In the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.

Dosage :
INTRAVENOUS INFUSION :
15mg/kg body weight diluted in 300-500ml of 5% glucose given over a period of 4 hours.
INTRAVENOUS INJECTION :
12mg/kg bodyweight daily for 3 consecutive days, followed by 6mg/kg I.V. on the 5th, 7th and 9th days.
MAINTENANCE THERAPY :
5 - 10mg/kg body weight by I.V. injection once a week.
Dosage Adjustment :
Renal Impairment: Administer with caution.
Hepatic Impairment: Administer with caution.

Packing :
1 Pack of 5 Ampoules of 250 mg/5 ml
1 Pack of 5 Ampoules of 500 mg/10 ml
Request
Callback
Yes! I am Interested

Etoposide Capsules 50mg

Etoposide Capsules 50mg
  • Etoposide Capsules 50mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging TypeStrip
BrandUnited BIotech
GenderUnisex
Packaging Size1 Strip of 10 Capsules

Indications :
  • Small cell lung cancer
  • Refractory testicular tumors

Dosage :
ORAL : 2 times 35 mg/m2/ day for 4 days to 50 mg/m2/day for 5 days.
IV : 35 mg/m2/ day for 4 days to 50 mg/m2/day for 5 days
IV : 50 to 100 mg/m2/day on days 1 through 5 to 100 mg/m2/day on days 1, 3 and 5.

Packing :
1 Strip of 10 Capsules

Request
Callback
Yes! I am Interested

Capecitabine Tablets 500mg

Capecitabine Tablets 500mg
  • Capecitabine Tablets 500mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageHospital
Packaging Size1 Strip of 10 Tablets
Packaging TypeStrip
BrandUnited Biotech

Indications :
  • Adjuvant in colorectal cancer Stage III Dukes' C - used as first-line monotherapy.
  • Metastatic colorectal cancer - used as first-line monotherapy, if appropriate.
  • Metastatic breast cancer - used in combination with docetaxel, after failure of anthracycline-based treatment.
  • Route of Administration : for oral use only
Dosage :
The usual starting dose is 2,500 mg/m2/day in two divided doses, 12 hours apart. One cycle includes two weeks of treatment followed by one week without treatment. Cycles can be repeated every three weeks.
Dose Adjustments
Renal Impairment :
Required.
Hepatic Dysfunction : In patients with mild to moderate hepatic dysfunction due to liver metastases, no starting dose adjustment is necessary; however, patients should be carefully monitored. Patients with severe hepatic dysfunction have not been studied.


Request
Callback
Yes! I am Interested

Gefitinib Tablets 250mg

Gefitinib Tablets 250mg
  • Gefitinib Tablets 250mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength250 mg
Packaging TypeTablet box
Packaging Size1 Strip of 10 Tablets

Indications :
  • Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Dosage :
ADULT: 250 mg tablet once a day, taken with or without food.
Dosage Adjustment :
Renal Impairment : Not Required in mild to moderate renal impairment.
Hepatic Impairment: Administer with caution.

Packing:
1 Strip of 10 Tablets
Request
Callback
Yes! I am Interested

Cyclophosphamide Tablets 50mg And Inj. 200mg, 500mg Tablets

Cyclophosphamide Tablets 50mg And Inj. 200mg, 500mg Tablets
  • Cyclophosphamide Tablets 50mg And Inj. 200mg, 500mg Tablets
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength500 mg
Packaging TypeTablet
Packaging Size1 Strip of 10 Tablets

Indications :

  • Malignant Disease :
  • Malignant lymphomas (Stages III and IV of the Ann Arbor staging system).
  • Non-Malignant Disease: Biopsy proven minimal change nephrotic syndrome in children
  • Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), Mixed-cell type lymphoma.
  • Histiocytic lymphoma.
  • Burkitt's lymphoma.
  • Multiple myelomas.
  • Mycosis Fungoides

Dosages :
ADULTS AND CHILDREN :
General Oral Dosage: 400mg/m2 once daily for 5 days.
Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment: Not required.

Packing :
1 Strip of 10 Tablets
1 Vial of 200 mg
1 Vial of 500 mg
1 Vial of 1000 mg

 

Request
Callback
Yes! I am Interested

Cytarabine Injection

Cytarabine Injection
  • Cytarabine Injection
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (e.g. 1 mg or 1 ml )500 mg
Packaging TypeVial with stopper
Packaging Size (e.g. 440 mg/ml)1 Vial of 100 mg

Indications :

  • Acute nonlymphocytic leukemia
  • Meningeal leukaemia

Dosages :
Normal adult dosage:  Doses of up to 200mg/m2 daily as a continuous IV infusion over 24 hours for 5 days. Total 1000mg/m2.
Single agent therapy:  IV infusion for five days (120 hours) repeated at approximately two weekly intervals.
Meningeal Leukaemia:  Intrathecally 5 mg/m2 to 75 mg/m2 body surface area OD for 4 days to once every 4 days.
Combination Therapy : 100 to 200 mg/m2 per day by continuous IV infusion (days 1 to 7) or 100 mg/m2 IV every 12 hrs (days 1-7).
Dosage Adjustment :
Renal Impairment : Not Necessary.
Hepatic Impairment: Required.

Packing :
1 Vial of 100 mg
1 Vial of 500 mg
1 Vial of 1000 mg

 

Request
Callback
Yes! I am Interested

Hydroxyurea Capsules 500mg

Hydroxyurea Capsules 500mg
  • Hydroxyurea Capsules 500mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength500 mg
Packaging TypeBox
Packaging Size1x10 strip

Indications :

  • Myeloma.
  • Resistant chronic myelotic leukemia.
  • Recurrent,Metastatic or inoperable carcinoma of the ovary.
  • Primary squamous cell(epidermal) carcinomas of the head and the neck cancer, excluding the lip.
  • Melanoma

Dosage :
  • ADULTS : Initial doses is 150 mg/m2 once daily for 5 consecutive days per 25 days treatment.
  • INTERMITTENT THERAPY : 80mg/kg administered orally as a single dose every third day.
  • CONTINUOUS THERAPY : 20 to 30 mg/kg administered orally as a single dose daily.
  • Dosage Adjustment :
  • Renal Impairment : Required.
  • Hepatic Impairment : Administer with caution.
  • Packing : 1 Strip of 10 Capsules 

 

Request
Callback
Yes! I am Interested

Pemetrexed for Injection 100mg and 500mg

Pemetrexed for Injection 100mg and 500mg
  • Pemetrexed for Injection 100mg and 500mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageCommercial, Clinical
Packaging Size100mg, 500 mg
BrandUnited Biotech

Indications :
  • Mesothelioma
  • Non-Small Cell Lung Cancer

Dosage :
Malignant Pleural Mesothelioma : 500 mg/m² administered as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m² infused over 2 hours beginning approximately 30 minutes after the end of pemetrexed administration.
Non-Small Cell Lung Cancer : The recommended dose of pemetrexed is 500 mg/m² administered as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle.
Dosage Adjustment :
Renal Impairment : Administer with caution.
Hepatic Impairment : Not Required but administer with caution.
Request
Callback
Yes! I am Interested
X

Explore more products



Reach Us
United Biotech (Manager)
FC/B-1 Extension, Mohan Cooperative Industrial Estate Mathura Road
Badarpur, New Delhi- 110044, Delhi, India



Call Us

Share Us

F GT L


Send E-mailSend SMS